Acta Pharmacologica Sinica (2009) 30: 702-714; doi: 10.1038/aps.2009.37

 
Review
[ Full text ]
 

Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance

 

Merouane BENCHERIF*

 
Preclinical Research, Targacept, Inc, Winston-Salem , NC 27101 , USA
 

A number of studies have confirmed the potential for neuronal nicotinic acetylcholine receptor (NNR)-mediated neuroprotection and, more recently, its anti-inflammatory effects.  The mechanistic overlap between these pathways and the ubiquitous effects observed following diverse insults suggest that NNRs modulate fundamental pathways involved in cell survival.  These results have wide-reaching implications for the design of experimental therapeutics that regulate inflammatory and anti-apoptotic responses through NNRs and represent an initial step toward understanding the benefits of novel therapeutic strategies for the management of central nervous system disorders that target neuronal survival and associated inflammatory processes

 

Keywords: neuroprotection; inflammation; nicotinic receptors; second messengers

 
 

* Correspondence to Dr Merouane BENCHERIF MD, PhD.
E-mail merouane.bencherif@targacept.com
Received 2009-01-22    Accepted 2009-03-09

[ Full text ]
 

Copyright©APS 2009
Add: 294 Tai-Yuan Road, Shanghai 200031, China
Phn: 86-21-5492-2821  Fax: 86-21-5492-2823
E-mail: aps@mail.shcnc.ac.cn